Concepedia

Linda Yau

LY

16

Publications

3K

Citations

12

H-Index

1980

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Orlando Immunology Center

George Washington University

Sidney Kimmel Cancer Center

Linda Yau is an author at Research Triangle Park Foundation specializing in medicine, virology, and clinical trials.

Top concepts

Publications per year

1980–2020

16

Publications

16

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama, Jian Han, Linda Yau et al. · New England Journal of Medicine · 2020 · 1.3K citations · Full text

Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer

Fotios Loupakis, Dongyun Yang, Linda Yau et al. · JNCI Journal of the National Cancer Institute · 2015 · 489 citations · Full text

Intent-to-Treat Analysis for Longitudinal Studies with Drop-Outs

Roderick J. A. Little, Linda Yau · Biometrics · 1996 · 383 citations

, , +13

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Joseph J. Eron, Patrick Yéni, Joseph Gathe et al. · The Lancet · 2006 · 341 citations

, , +9

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

Kimberly Y. Smith, Parul Patel, Derek M. Fine et al. · AIDS · 2009 · 217 citations

Rows per page

1–5 of 16